Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors

Nosha Farhadfar, MD, Debra Lynch Kelly, PhD, Lacey E. Mead, BS, Shalini Nair, Randy A. Brown, MD, John W. Hiemenz, MD, Jack W. Hsu, MD, Hemant S. Murthy, MD, W. Stratford May, MD PhD, John R. Wingard, MD, Wendy J Dahl, PhD

Blood (2019) 134 (Supplement_1): 4565.

https://doi.org/10.1182/blood-2019-127648

Published: 2019

Journal Articles

Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center

Forat Lutfi, MD, William Paul Skelton, IV, MD, Emma Rosenau, Nosha Farhadfar, MD, Hemant S. Murthy, MD, W. Stratford May, MD PhD, John W. Hiemenz, MD, Christopher R. Cogle, MD, Randy A. Brown, MD, Sarah Wheeler, RPH, John R. Wingard, MD, Maxim Norkin, MD

Blood (2017) 130 (Supplement 1): 4529.

https://doi.org/10.1182/blood.V130.Suppl_1.4529.4529

Published: 2017

Journal Articles

PKR Inhibits Hematopoietic Stem Cell Differentiation

Richard L Bennett, PhD, Michael T. Byrne, DO, Xiaodong Cheng, MD PhD, Mohini Patel, Zeel Patel, Amalin Asous, W. Stratford May, MD PhD

Blood (2015) 126 (23): 2443.

https://doi.org/10.1182/blood.V126.23.2443.2443

Published: 2015

Journal Articles

A New Model to Predict Remission Status in Acute Myeloid Leukemia (AML) Patients Based on Day 14 Bone Marrow (D14 BM) Biopsy

Maxim Norkin, MD PhD, Myron Chang, PhD, An Qi, PhD, Helen Leather, BPharm, Lakshmikanth Katragadda, MD, Ying Li, MD PhD, Jan S Moreb, MD, W. Stratford May, MD PhD, Randy A. Brown, MD, Jack W. Hsu, MD, John W Hiemenz, MD, John R Wingard, MD, Christopher R. Cogle, MD

Blood (2015) 126 (23): 3852.

https://doi.org/10.1182/blood.V126.23.3852.3852

Published: 2015

Journal Articles

Minimal Residual Disease (MRD) By Either Flow Cytometry or Cytogenetics Prior to an Allogeneic Hematopoietic Cell Transplant (allo-HCT) Predicts Poor Acute Myeloid Leukemia (AML) Outcomes

Lakshmikanth Katragadda, MD, Maxim Norkin, MD PhD, Myron Chang, PhD, Yunfeng Dai, PhD, Jan S Moreb, MD, W. Stratford May, MD PhD, Christopher R. Cogle, MD, Helen Leather, BPharm, Ying Li, MD PhD, Lamis K Eldjerou, MD, John W Hiemenz, MD, Randy A. Brown, MD, John R. Wingard, MD

Blood (2015) 126 (23): 3221.

https://doi.org/10.1182/blood.V126.23.3221.3221

Published: 2015

Journal Articles

Effect of Melphalan 140 Mg/m 2 Versus 200 Mg/m 2 on Toxicities and Outcomes in Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Transplantation

Lakshmikanth Katragadda, MD, Lindsay McCullough, MD, Yunfeng Dai, PhD, Jack W Hsu, MD, John W Hiemenz, MD, W. Stratford May, MD PhD, Christopher R. Cogle, MD, Maxim Norkin, MD PhD, Randy A Brown, MD, John R. Wingard, MD, Myron Chang, PhD, Jan S Moreb, MD

Blood (2015) 126 (23): 1988.

https://doi.org/10.1182/blood.V126.23.1988.1988

Published: 2015

Journal Articles

Increased PKR Expression Promotes MDS Evolution to Acute Leukemia in the NHD13 Mouse Model

Michael T. Byrne, DO, Richard L Bennett, PhD, Xiaodong Cheng, MD, PhD, Christopher M Carter, MD, W. Stratford May, MD PhD

Blood (2014) 124 (21): 1900.

https://doi.org/10.1182/blood.V124.21.1900.1900

Published: 2014

Journal Articles

PKR Inhibits the DNA Damage Response and Correlates with Poor Clinical Outcomes in AML

Xiaodong Cheng, MD, PhD, Michael T. Byrne, DO, Kevin Brown, PhD, Marina Konopleva, MD PhD, Steven M. Kornblau, MD, Richard L Bennett, PhD, W. Stratford May, MD PhD

Blood (2014) 124 (21): 1017.

https://doi.org/10.1182/blood.V124.21.1017.1017

Published: 2014

Journal Articles

Clinical and Laboratory Factors Influencing The Probability Of Complete Remission In AML Patients With Positive Day 14 Bone Marrows

Maxim Norkin, MD, PhD, Jan Moreb, MD, Helen Leather, BPharm, Randy A. Brown, MD, Jack W. Hsu, MD, John W Hiemenz, MD, W. Stratford May, MD, PhD, Myron N Chang, PhD, Qi An, Ying Li, MD, PhD, Christopher R Cogle, MD, John R Wingard, MD

Blood (2013) 122 (21): 1412.

https://doi.org/10.1182/blood.V122.21.1412.1412

Published: 2013

Journal Articles

Effect Of Cumulative Adverse Clinical Risk Factors On Patients With Multiple Myeloma Undergoing First GCSF Apheresis

Ilicia L. Shugarman, MD, Randy A Brown, MD, Christopher R Cogle, MD, John W Hiemenz, MD, W. Stratford May, MD, PhD, Maxim Norkin, MD, PhD, Helen Leather, BPharm, Xiaomin Lu, Michele W. Sugrue, John R. Wingard, MD, PhD, Jan Moreb, MD, Jack W Hsu

Blood (2013) 122 (21): 4520.

https://doi.org/10.1182/blood.V122.21.4520.4520

Published: 2013

Journal Articles

CECA Results in Improved Response Rates and Ability to Proceed to Stem Cell Transplantation in Adult Refractory or Relapsed Acute Myeloid Leukemia

Sukanthini Subbiah, MD, Randy A. Brown, MD, Myron N Chang, PhD, Christopher R Cogle, M.D., John W. Hiemenz, MD, W. Stratford May, MD, PhD, Jan Moreb, MD, Maxim Norkin, MD, PhD, John R. Wingard, MD, Baldeep Wirk, MD, Jack W Hsu, MD

Blood (2011) 118 (21): 4299.

https://doi.org/10.1182/blood.V118.21.4299.4299

Published: 2011

Journal Articles

Aberrant Ras Activation Associated with Functional Loss of Tnk1/Kos1 In Human B-Cell Lymphoma

Kishalay Hoare, Ph.D, Sarasija Hoare, Ph.D, Bernadette Zamora, DVM, PhD., DACLAM, Tammy Flagg, Ann Dongtao Fu, MD, PhD, HT(ASCP), QIHC, Steve McClellan, Margaret A. Shipp, MD, Mary Reinhard, DVM, DACLAM, W. Stratford May, MD, PhD

Blood (2010) 116 (21): 3159.

https://doi.org/10.1182/blood.V116.21.3159.3159

Published: 2010

Journal Articles

Expression of JAZ in Multiple Myeloma and Its Potential Role as A Novel Molecular Target.

Mingli Yang, PhD, Jingxin Qiu, MD, PhD, Ying Li, MD, PhD, David Ostrov, PhD, Jinghua Jia, PhD, W. Stratford May, MD, PhD

Blood (2009) 114 (22): 2862.

https://doi.org/10.1182/blood.V114.22.2862.2862

Published: 2009

Journal Articles

Mechanisms of Apoptosis Induction by BH3 Inhibitor ABT-737 in AML.

Michael Andreeff, MD, PhD, Rooha Contractor, Peter P. Ruvolo, PhD, Xingming Deng, MD, PhD, Ismael Samudio, PhD, Yue-Xi Shi, Teresa McQueen, BS, Rui-Yu Wang, MD, PhD, Wendy Schober, Xiaoyang Ling, PhD, Frank C. Marini, PhD, David Harris, Zeev Estrov, MD, James McCubrey, PhD, W. Stratford May, MD, PhD, Marina Konopleva, MD, PhD

Blood (2005) 106 (11): 244.

https://doi.org/10.1182/blood.V106.11.244.244

Published: 2005

NARROW

Diet Quality of Long-Term Allogeneic and Autologous Stem Cell Transplant (HCT) Survivors

Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center

PKR Inhibits Hematopoietic Stem Cell Differentiation

A New Model to Predict Remission Status in Acute Myeloid Leukemia (AML) Patients Based on Day 14 Bone Marrow (D14 BM) Biopsy

Minimal Residual Disease (MRD) By Either Flow Cytometry or Cytogenetics Prior to an Allogeneic Hematopoietic Cell Transplant (allo-HCT) Predicts Poor Acute Myeloid Leukemia (AML) Outcomes

Effect of Melphalan 140 Mg/m 2 Versus 200 Mg/m 2 on Toxicities and Outcomes in Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Transplantation

Increased PKR Expression Promotes MDS Evolution to Acute Leukemia in the NHD13 Mouse Model

PKR Inhibits the DNA Damage Response and Correlates with Poor Clinical Outcomes in AML

Clinical and Laboratory Factors Influencing The Probability Of Complete Remission In AML Patients With Positive Day 14 Bone Marrows

Effect Of Cumulative Adverse Clinical Risk Factors On Patients With Multiple Myeloma Undergoing First GCSF Apheresis

CECA Results in Improved Response Rates and Ability to Proceed to Stem Cell Transplantation in Adult Refractory or Relapsed Acute Myeloid Leukemia

Aberrant Ras Activation Associated with Functional Loss of Tnk1/Kos1 In Human B-Cell Lymphoma

Expression of JAZ in Multiple Myeloma and Its Potential Role as A Novel Molecular Target.

Mechanisms of Apoptosis Induction by BH3 Inhibitor ABT-737 in AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only